Questionnaires and assessment of airway caliber Jean-Luc Malo MD Chest Physician Université de Montréal and Hôpital du Sacr é -Coeur and Center for Asthma.

Slides:



Advertisements
Similar presentations
Predicting risks of asthma recurrence Stephen Watt Consultant in Respiratory and Hyperbaric Medicine Aberdeen Royal Infirmary.
Advertisements

Pulmonary Function Testing
BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.
Bronchoprovocation test Presented by: Ashraf Abbas ELMaraghy,MD. Lecturer of Chest Diseases, Ain Shams University.
or more simply.. -asthma is a condition of paroxysmal reversible airway obstruction which is characterised by : Airflow limitation ( reversible) Airway.
Respiratory Function Tests RFTs
Program: CIHR Centers for Research Development: Understanding/Addressing Physico-Social Environment, Financial partners: IRSST.
Physiology Lab Spirometry
Eosinophilic bronchitis. Exercise, cold air Eosinophilic bronchitis Airway hyperresponsiveness Late asthmatic reaction Early asthmatic reaction Allergen.
2008 Guidelines 2.4 DIAGNOSIS IN ADULTS (1) -based on the recognition of a characteristic pattern of symptoms and signs and the absence of an alternative.
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
Bronchial provocation Tests or Bronchial challenge Test
Asthma What is Asthma ? V1.0 1997 Merck & ..
Definition of COPD COPD is defined by GOLD (2014 update) as:*
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
Chronic Obstructive Pulmonary Disease and Asthma: All That Wheezes? Clifford Courville, MD Pulmonary, Allergy, and Critical Care.
Respiratory function tests
Diagnosing asthma History & Physical examination Measurements of lung function – Spirometry – Peak expiratory flow Measurements of airway hyperresponsiveness.
Respiratory Function Test Department of internal medicine Chen Yu.
Serial assessment of peak expiratory flows Jean-Luc Malo MD Chest Physician Université de Montréal and Hôpital du Sacr é -Coeur and Center for Asthma in.
Respiratory Impairment and Disability A. H. Mehrparvar, M.D.
Questionnaires for clinical and epidemiological purposes Manon Labrecque,M.D., M.Sc.
Respiratory Function Tests Fiona Gilmour SHO 03/06/04.
Diagnostic Strategies for Occupational Asthma Louis-Philippe Boulet, MD, FRCPC Institut de cardiologie et de pneumologie de l’Université Laval, Hôpital.
Spirometry (Pulmonary Function Tests)
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
PEDIATRIC ASTHMA Anna M. Suray, M.D Respiratory Update Weirton Medical Center March 17, 2008.
The effect of shift work on serial peak expiratory flow measurements used to diagnose occupational asthma Vicky Moore, Maritta Jaakkola, Cedd Burge, Charles.
Respiratory Function Test Department of internal medicine Chen Yu.
Assessing Risk (Future) Domain – Of adverse events in the future, especially of exacerbations and of progressive, irreversible loss of pulmonary function—is.
Normal and abnormal Prof. J. Hanacek, MD, PhD
Asthma Diagnosis: Anatomy and Pathophysiology of Asthma Karen Meyerson, MSN, RN, FNP-C, AE-C Asthma Network of West Michigan April 21, 2009 Acknowledgements:
Psycho-socio-economic impact of occupational asthma Olivier Vandenplas Department of Chest Medicine Mont-Godinne Hospital Catholic University of Louvain.
Tools in the investigation of asthma in the workplace Jean-Luc Malo MD Hôpital du Sacré-Cœur de Montréal Université de Montréal.
1 Pulmonary Function Tests J.B. Handler, M.D. Physician Assistant Program University of New England.
Occupational asthma What is an occupational asthma?
Component 1: Measures of Assessment and Monitoring n Two aspects: –Initial assessment and diagnosis of asthma –Periodic assessment and monitoring.
Pulmonary Function David Zanghi M.S., MBA, ATC/L, CSCS.
Pulmonary Function Measurements
Asthma A Presentation on Asthma Management and Prevention.
Spirometry A. H. Mehrparvar, MD Occupational Medicine department Yazd University of Medical Sciences.
Diagnosing and Staging Asthma*
Pulmonary Function Tests (PFTs)
Respiratory Function Tests RFTs. Review Of Anatomy & physiology Lungs comprised of  Airways  Alveoli.
Maggie Harris Independent Respiratory Nurse Specialist
ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.
Definition of asthma Asthma is a heterogeneous disease, usually characterized by chronic airway inflammation. It is defined by the history of respiratory.
L U N G COMPLIANCE ? Physiology Unit.
Pulmonary function test. Evaluation of pulmonary function is important in many clinical situations evaluation of a variety of forms of lung disease assessing.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
Asthma 1 د. ميريانا البيضة. DIAGNOSIS 2 3 Definition of asthma.
Pulmonary function tests & Lung volumes & capacities Prof. Omer Abdel Aziz.
Clinical Applications of Spirometry for Pediatric Asthma
Pulmonary Function Tests Pulmonary Function Tests Marcus A. Nesbeth PA-C June 19, 2009.
RECOGNITION OF OCCUPATIONAL ASTHMA IN SLOVENIA RECOGNITION OF OCCUPATIONAL ASTHMA IN SLOVENIA Assist. Prof. Alenka Franko, MD, PhD.
Dr Mazen Qusaibaty MD, DIS / Head Pulmonary and Internist Department Ibnalnafisse Hospital Ministry of Syrian health – Dr Mazen.
Research where it is most needed National Respiratory Strategy
Pulmonary response in sarcoidosis
Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation  Nicholas J. Gross, MD,
Is data quality more important than data quantity in the diagnosis of occupational asthma from serial PEF records? MOORE VC, BURGE CBSG, AND BURGE PS Occupational.
Immunostaining for lipid peroxidation product 4-hydroxy-2-nonenal (4-HNE) adduct in the lungs of smokers with and without chronic obstructive pulmonary.
Evidence-Based Asthma Guidelines
Level of physical activity by Global Initiative for Obstructive Lung Disease (GOLD) stage, BODE (body mass index, FEV1 for airflow obstruction, dyspnoea,
Representative diaphragm electromyogram (EMG) tracings at rest (a and b) and during maximum voluntary ventilation (c and d) in a healthy subject (a and.
Spirometry A. H. Mehrparvar, MD Occupational Medicine department
3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).
Correlation between inspiratory capacity (IC)/total lung capacity (TLC) ratio and oxygen pulse at peak exercise in chronic obstructive pulmonary disease.
Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification based on symptom and risk evaluation. a) GOLD model of symptom/risk evaluation.
Chronic obstructive pulmonary disease (COPD) prevalence (postbronchodilator FEV1/FVC (forced expiratory volume in 1 s/forced vital capacity)
Assessment of patients with possible occupational asthma.
Presentation transcript:

Questionnaires and assessment of airway caliber Jean-Luc Malo MD Chest Physician Université de Montréal and Hôpital du Sacr é -Coeur and Center for Asthma in the Workplace Hôpital du Sacré-Cœur de Montréal Université de Montréal Axe de recherche en santé respiratoire Centre asthme et travail Center for Asthma in the Workplace

European Respiratory Society asthma questionnaire Validated from 1989 onwards Addition of questions on symptoms related to work See:

Predictive values of this questionnaire

Validity of open clinical questionnaires 1991: Prospective clinical assessment of 162 patients referred for possible occupational asthma. Malo JL et al. Am Rev Respir Dis 1991 Sensitivity: 87 % Specificity: 55 % Positive predictive value: 63 % Negative predictive value: 83 % 1995: Most helpful questions (Eur Respir J)

Symptoms at workOR95% CIp Wheezing Loss of voice Nasal itching Ocular itching Subjects exposed to high-molecular-weight agents Wheezing Loss of voice Nasal itching Subjects exposed to low-molecular-weight agents No symptom significantly associated with occupational asthma Questionnaire items most likely to be associated to the presence or absence of occupational asthma * * Vandenplas O. et al. Eur respir J 2005; 26:1056

Chronic Obstructive Pulmonary Diseases Definition (functional) Diseases characterized by a reduction in expiratory flow rates caused by either bronchial obstruction (bronchial involvement per se) or a loss in the elastic support of the bronchi by emphysema (destruction of the lung parenchyma) (peribronchial involvement).

Manifestations: reduction of expiratory flow rates Functional indices: 1. Forced expiratory volume-one second (FEV1) 2. FEV1/forced vital capacity (“Tiffeneau Index”, 1947) 3. Peak Expiratory Flows (Rates): Wright and McKerrow 1959 Chronic Obstructive Pulmonary Diseases

flow (volume / time) peak expiratory flow one second time maximum inspiratory capacity (vital capacity) FEV1 forced vital capacity

Origin of the assessment of peak expiratory flows (PEF) in Asthma and Occupational Asthma In asthma  Daily peak flow measurements in the assessment of steroid therapy for airway obstruction.Epstein SW, Fletcher CM, Oppenheimer EA. BMJ 1969  On observing patterns of airflow obstruction in chronic asthma.Turner-Warwick M. Br J Dis Chest 1977 Identification of three patterns: 1. Brittle asthmatic; 2. Morning dipper; 3. Pseudo irreversible asthmatic.  Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Hetzel MR, Clark TJH. Thorax  Action plans based on PEF. In occupational asthma  Burge PS et al onwards

Interest, advantages  assessment with portable, cheap instruments  provides serial assessment of airway caliber (relevant for asthma diagnosis and management) Disadvantages  effort-dependent manoeuver  reflects large airway caliber (discredit from lung physiologists who focused on «small airways»)

To assess peak expiratory flows : Portable peak flow meters : standard (cheap) and electronic (storage of data) Predicted values (as a function of age, sex, height and racial origin) Normal values In men: 500 to 700 L/min In women: L/min

Number of recordings/day: In asthma: morning value (before medication) In occupational asthma: at least four times a day How many values at each time ? 3 times, 2 best values within 20 L/min Significant changes ? 50 L/min In occupational asthma, for how long ? Two weeks at work, two weeks off-work

Indications In asthma Acute: essential in ER (FEV1 or PEF) and in GP office Chronic: Poor perception of airflow limitation Brittle asthma Discrepancy between symptoms and need for medication: exclude hyperventilation To identify flare-ups In occupational asthma As a screening test : negative tracing and absence of airway hyper- responsiveness at work Diagnostic ? In rhinitis Nasal peak flows can be assessed.

Examples of tracings

Development of an expert system for interpretation of PEF by Burge PS and coworkers * Two methods for assessing PEF: 1.Visual examination by experts: satisfactory within- and between- observers’ reproducibility 2. Interpretation by discriminant analysis (OASYS) * Burge PS et al. Occup Environ Med 1999; 56:

Pitfalls  Compliance: poor (50%) in asthma and in occupational asthma (Quirce & Chan-Yeung 1995)  Falsification of data : 20% of values are invented  Interpretation of data: visual vs computed- assisted method (OASYS) ?  contamination of results in field studies  variable figures for sensitivity and specificity by comparison with specific inhalation challenges (gold standard)

Girard D et al. Am J Respir Crit Care Med 2004; 170: Girard F et al. Am J Respir Crit Care Med 2004

Conclusion Advantages  assess subjects in a natural setting  simplicity: inexpensive and handy devices  readily available  as a screening test, more to exclude than to confirm the diagnosis Limitations  subject’s motivation and honesty  long monitoring may be necessary  return to work without supervision  interpretation of results

Compatible clinical history and exposure to possible causal agents Skin testing and/or specific IgE assessment (if possible) Assessment of bronchial responsiveness to pharmacologic agents NormalIncreased Subject still at work Subject no longer at work Subject still at work Laboratory challenges with the suspected occupational agent PositiveNegative Consider return to work Workplace or laboratory challenges with the suspected occupational agent, peak expiratory flow monitoring, or both PositiveNegative No asthma Occupational asthma Nonocccupational asthma Chan Yeung M, Malo JL. NEJM 1995; 333:107